Anson Funds Management LP - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESW and the CUSIP is 81362J118. A total of 8 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Anson Funds Management LP ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q3 2018$2,538,000
+14.5%
1,335,5610.0%0.91%
-30.3%
Q2 2018$2,217,000
-13.7%
1,335,561
-0.2%
1.30%
-32.1%
Q1 2018$2,568,000
+0.2%
1,337,580
-0.3%
1.91%
+10.7%
Q4 2017$2,562,000
+59.1%
1,341,2800.0%1.73%
+614.5%
Q3 2017$1,610,000
-5.2%
1,341,280
-0.5%
0.24%
-55.0%
Q2 2017$1,699,0001,348,6800.54%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Anson Funds Management LP 1,337,580$2,568,0001.91%
Glassman Wealth Services 19,954$17,0000.01%
Psagot Value Holdings Ltd. 38,653$32,0000.00%
BNP PARIBAS FINANCIAL MARKETS 446,256$361,467,0000.00%
MORGAN STANLEY 443$00.00%
Financial Architects, Inc 1,406$1,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 394,717$339,0000.00%
UBS Group AG 6,047$5,0000.00%
IFP Advisors, Inc 692$1,0000.00%
NOMURA HOLDINGS INC 62,701$48,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders